These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
228 related articles for article (PubMed ID: 29395543)
1. Reconciling a "pleasant exchange" with evidence of information bias: A three-country study on pharmaceutical sales visits in primary care. Reynolds E; Guénette L; Lexchin J; Cassels A; Wilkes MS; Durrieu G; Beaulieu MD; Mintzes B Health Policy; 2018 Mar; 122(3):250-255. PubMed ID: 29395543 [TBL] [Abstract][Full Text] [Related]
2. Pharmaceutical sales representatives and patient safety: a comparative prospective study of information quality in Canada, France and the United States. Mintzes B; Lexchin J; Sutherland JM; Beaulieu MD; Wilkes MS; Durrieu G; Reynolds E J Gen Intern Med; 2013 Oct; 28(10):1368-75. PubMed ID: 23558775 [TBL] [Abstract][Full Text] [Related]
3. Interactions between physicians and the pharmaceutical industry generally and sales representatives specifically and their association with physicians' attitudes and prescribing habits: a systematic review. Fickweiler F; Fickweiler W; Urbach E BMJ Open; 2017 Sep; 7(9):e016408. PubMed ID: 28963287 [TBL] [Abstract][Full Text] [Related]
5. Influence of pharmaceutical promotion on prescribers in Jordan. Altawalbeh SM; Ibrahim IA; Al-Shatnawi SF Int J Clin Pharm; 2020 Apr; 42(2):744-755. PubMed ID: 32140917 [TBL] [Abstract][Full Text] [Related]
6. Unwarranted claims of drug efficacy in pharmaceutical sales visits: are drugs approved on the basis of surrogate outcomes promoted appropriately? Habibi R; Lexchin J; Mintzes B; Holbrook A Br J Clin Pharmacol; 2017 Nov; 83(11):2549-2556. PubMed ID: 28664660 [TBL] [Abstract][Full Text] [Related]
7. Effects of Physician-directed Pharmaceutical Promotion on Prescription Behaviors: Longitudinal Evidence. Datta A; Dave D Health Econ; 2017 Apr; 26(4):450-468. PubMed ID: 26893065 [TBL] [Abstract][Full Text] [Related]
8. Physicians, pharmaceutical sales representatives, and the cost of prescribing. Caudill TS; Johnson MS; Rich EC; McKinney WP Arch Fam Med; 1996 Apr; 5(4):201-6. PubMed ID: 8769907 [TBL] [Abstract][Full Text] [Related]
9. Perceptions and Attitudes of Egyptian Health Professionals and Policy-Makers towards Pharmaceutical Sales Representatives and Other Promotional Activities. Kamal S; Holmberg C; Russell J; Bochenek T; Tobiasz-Adamczyk B; Fischer C; Tinnemann P PLoS One; 2015; 10(10):e0140457. PubMed ID: 26473484 [TBL] [Abstract][Full Text] [Related]
10. Physicians' perceptions of medical representative visits in Yemen: a qualitative study. Al-Areefi MA; Hassali MA; Ibrahim MI BMC Health Serv Res; 2013 Aug; 13():331. PubMed ID: 23962304 [TBL] [Abstract][Full Text] [Related]
11. Interactions between physicians and the pharmaceutical industry: what does the literature say? Lexchin J CMAJ; 1993 Nov; 149(10):1401-7. PubMed ID: 8221424 [TBL] [Abstract][Full Text] [Related]
12. Pharmaceutical sales representatives and the doctor/patient relationship. Wall LL; Brown D Obstet Gynecol; 2002 Sep; 100(3):594-9. PubMed ID: 12220784 [TBL] [Abstract][Full Text] [Related]
13. How does direct-to-consumer advertising (DTCA) affect prescribing? A survey in primary care environments with and without legal DTCA. Mintzes B; Barer ML; Kravitz RL; Bassett K; Lexchin J; Kazanjian A; Evans RG; Pan R; Marion SA CMAJ; 2003 Sep; 169(5):405-12. PubMed ID: 12952801 [TBL] [Abstract][Full Text] [Related]
14. [Attitudes of general practitioners to pharmaceutical sales representatives in Sousse]. Ben Abdelaziz A; Harrabi I; Rahmani S; Ghedira A; Gaha K; Ghannem H East Mediterr Health J; 2003; 9(5-6):1075-83. PubMed ID: 16450540 [TBL] [Abstract][Full Text] [Related]
15. Drug promotional activities in Nigeria: impact on the prescribing patterns and practices of medical practitioners and the implications. Fadare JO; Oshikoya KA; Ogunleye OO; Desalu OO; Ferrario A; Enwere OO; Adeoti A; Sunmonu TA; Massele A; Baker A; Godman B Hosp Pract (1995); 2018 Apr; 46(2):77-87. PubMed ID: 29426263 [TBL] [Abstract][Full Text] [Related]
16. Pharmaceutical drug marketing strategies and tactics: a comparative analysis of attitudes held by pharmaceutical representatives and physicians. Parker RS; Pettijohn CE Health Mark Q; 2005; 22(4):27-43. PubMed ID: 16597582 [TBL] [Abstract][Full Text] [Related]
17. The attitude and acceptability towards medical promotional tools and their influence on physicians' prescribing practices in Jordan and Iraq: a cross-sectional study. Ali KE; Naser AY; Al-Rousan R; Alwafi H; AbuAlhommos AK; Alsairafi ZK; Salawati EM; Samannodi M; Dairi MS BMC Health Serv Res; 2022 Jan; 22(1):105. PubMed ID: 35078461 [TBL] [Abstract][Full Text] [Related]
18. Report: Interactions and conflicts of interests between prescribers and medical sales representatives (MSRs) regarding prescribing and drug promotion practices in Karachi, Pakistan. Naqvi AA; Zehra F; Khan N; Ahmad R; McGarry K Pak J Pharm Sci; 2019 Mar; 32(2):687-695. PubMed ID: 31081784 [TBL] [Abstract][Full Text] [Related]
19. A survey of german physicians in private practice about contacts with pharmaceutical sales representatives. Lieb K; Brandtönies S Dtsch Arztebl Int; 2010 Jun; 107(22):392-8. PubMed ID: 20574555 [TBL] [Abstract][Full Text] [Related]